A malignant pheochromocytoma is described in a 71-year-old man. Osseous metastases became manifest 12 years after successful removal of the primary tumor which originated in paraganglionic tissue near the right adrenal gland. Although the patient had no symptomsof catecholamine excess initially, hypertension, tachycardia and excessive sweating appeared several months before his death, concomitantly with a sharp increase in noradrenaline secretion due to an accelerated growth of metastatic tumors. Since there is no histologic criterion of malignancy in this neoplasm, it would be prudent to consider every case of pheochromocytomaas potentially malignant and to followup carefully for a long time after removal of the primary tumor. (Internal Medicine 39: 820-825, 2000) 
Introduction
Malignant pheochromocytomais a rare neoplasm. The reported incidence varies from less than 1% to 19% of all pheochromocytomas (1) (2) (3) (4) (5) , and when the primary lesion is extraadrenal, this may rise to 24% (6) or 30% (7) . Recurrence usually occurs several years after removal of the primary tumor (5, 8, 9) , and bone is the most commonsite for metastases (8) . The diagnosis of malignant pheochromocytoma is difficult, because it cannot be defined based on histologic criterion, and the clinical manifestations overlap those seen in benign pheochromocytomaexcept for the mass effect of tumors in the late stage. Wereport here a patient with malignant pheochromocytoma which recurred 12 years after successful removal of the primary tumor. The patient had been asymptomatic and normotensive until several months before his death, when hypertension, tachycardia and excessive sweating appeared with a concomitant increase in noradrenaline secretion due to an accelerated growth of metastatic bone tumors.
Case Report
A 71-year-old man was admitted to Teikyo University Mizonokuchi Hospital on February 2, 1 998 complaining of neck pain and numbness in the right hand (2nd admission). There was no family history of clinically overt endocrine diseases. In 1986, the patient had episodes of right upper quadrant pain after taking fatty dishes. He underwent abdominal ultrasonography, which demonstrated, in addition to gallbladder stones, a right adrenal mass. Although the pain was shortly relieved by the use of spasmolytics, he was admitted to a hospital for evaluation of the incidentally-discovered adrenal tumor on April 30, 1986 (1st admission). The patient had never experienced paroxysms of headache, palpitation, excessive sweating, apprehension, flushing or other symptomscommonlyobserved in pheochromocytoma before. 1st admission Physical examination revealed no gross abnormality. Nostigmataof Cushing's syndromewerepresent. Theskin wasnormally perspirated, and was free of eruption and pigmentation.
No goiter or any other abnormal mass was found in the neck. There was no tumor palpable in the abdomen. His blood pressure on the day of admission was 138/88 mmHgwith a pulse rate of 80/min, which was not changed significantly by palpation of the abdomen. The blood pressure was 128/66 mmHg (pulse rate 72/min) on the 2nd hospital day, and had remained normal during the whole period of hospitalization.
Optic fundus did not show any hypertensive change. all within normal limits. A 75-g oral glucose tolerance test gave normal results with an appropriate insulin response. Chest Xray films revealed normal tardiac silhouette and normal pulmonary markings. An electrocardiogram showed regular sinus rhythm without evidence of ischemic changes.
Plasma levels of noradrenaline were elevated, while those of adrenaline and dopamine were normal (Table 1 ). In accordance with these results, 24 hours urinary excretion of noradrenaline and its metabolites , normetanephrine and vanillylmandelic acid (VMA), was clearly increased. Plasma renin activity and aldosterone concentration were normal and responded normally to stimulation by 2 hours of upright posture. Plasma cortisol, calcitonin and thyroid hormones as well as urinary 17-hydroxycorticosteroid excretion were within normal limits.
A CT scan showed a mass of4 cm in diameter in the right adrenal gland, which was stained immediately after the infusion of contrast medium. An MRIexamination revealed a high signal intensity lesion on T2-weighted images with multiple areas of low signal intensity inside suggesting necrotic changes (Fig. 1) . Noabnormal uptake was demonstrated in extra-adrenal sites by 131I-MIBG (metaiodobenzylguanidine) scintigraphy of the abdomenand chest. Based on these findings, a diagnosis of pheochromocytoma was made, and the patient underwent laparotomy on September 16, 1986 . A solid, encapsulated tumor, 50 g in weight, arising from the paraganglia adjacent to the right adrenal gland was found, and resected. No regional lymph nodes were enlarged. Cross sections of the tumor showedmultiple areas of hemorrhage and necrosis. Onlight microscopy, the tumor was composedof relatively large chromaffin cells arranged in small or large alveolar patterns with a typical "Zellballen" appearance ( Fig. 2A) . Neighboring groups of tumor cells were separated by a reticulin-rich fibrovascular stroma. Nuclear pleomorphism, mitotic figures or vascular and capsular invasion wasnot evident. Postoperative course was uneventful and without complications. After surgery, urinary VMAexcretion fell to within the normal range (7.8 mg/day), although the blood pressure at bed rest in the morning measured by sphygmomanometry ( 1 33±8/ 84±7, n=28) did not change significantly from that in the preoperative period (137±8/86±8, mean±SD, n=44). There was Table 1 again no significant difference in simultaneously measured pulse rates before and after surgery (74±7 vs 80±7, meardzSD). The patient was followed-up annually. He had normal blood pressure and his urinary VMA excretion in randomurine specimens remained normal during the period of observation. The patient had no pheochromocytoma-related symptoms during the period.
2nd admission In September 1996, the patient developed neck pain and visited an orthopedist. X-ray films of the cervical spine were normal, which was confirmed later by us. He was diagnosed as having cervical spondylosis and w£s given analgesics. Because of persistent neck pain and numbness in the right hand that appeared in the last few months, the patient presented to the orthopedic department of our hospital on October 29 1997, and a neck tumor wasdiscovered. Herefused admission for assessment of the tumor at that time. Finally, the patient was hospitalized on February 2, 1998. Upon physical examination, the blood pressure was 1 36/82 with a pulse rate of 84/min. A solid tumor, 5 cm in diameter, was noted on the right posterior side of the upper neck, which was attached to the spine and was not displaceable. Neurological examinations were negative.
The urine was normal, as were the results of routine hematologic, blood chemical and enzyme tests. Electrocardiogram and chest X-ray films were normal. Plasma levels of noradrenaline were markedly elevated, while those of adrenaline and dopamine were normal or marginally exceeded the upper ref-
erence limits (Table 1) . Concurrently, 24 hours urinary excretion of noradrenaline, normetanephrine and VMA was definitely increased. Plasma renin activity and plasma levels of aldosterone, calcitonin and thyroid hormones were within normal limits. Serum neuron-specific enolase (NSE) concentration was 8.7 ng/ml (normal range: less than 10 ng/ml). X-ray films of the spine showed destruction of spinous process of the 3rd cervical vertebra. An MRIrevealed a high signal intensity mass on T2-weighted images, which encircled the right half of the 3rd cervical vertebra and partly extended in both superior and inferior directions (Fig. 3) . The spinal cord was deviated to the left owing to compression by the tumor. A
CTscan of the abdomendemonstrated, in addition, a 2-cm mass in the left iliac wing. An 123I-MIBG scintigraphy showed abnormal accumulation in the neck and the left iliac bone (Fig.   4 ).
On the 5th day of admission, the patient suddenly developedweaknessof the musclesof the upper extremities, which rapidly extended to the shoulder, trunk and lower extremities. Examination disclosed a flaccid paresis and diminished tendon reflexes in the extremities, whereas pinprick, thermal and vibratory sensation were normal. Because of this progressive paraparesis, an emergency surgery was done on February 9, 1998, for decompression of the cervical spinal cord and the neck tumor was partially resected. Light microscopy of the tu- mor tissue revealed chromaffin cell tumor (Fig. 2B, 2C ). Grimelius stain revealed that the tumor cells were positive for neurosecretory granule (Fig. 2D) . The general features in histology were essentially the same as those of the initially-resected abdominal tumor. Immunochemistry showed that cells were positive for NSE, chromogranin and S I00 protein.
After surgery, plasma levels of noradrenaline as well as its urinary excretion gradually increased (Table 1) . His urinary noradrenaline excretion in June 1998 wasthree times as much as that determined soon after admission. Concomitantly, the blood pressure rose, and the patient had occasional episodes of palpitation and excessive sweating that occurred spontaneously and coincided in time with an elevation of blood pressure and an increase in pulse rate, hence suggesting the paroxysm of pheochromocytoma rather than autonomichyperreflexia. The hypertension was labile with morning blood pressure ranging from 124/70 to 176/106, which was controlled by the administration of phentolamine. Although his neurological symptoms were temporarily improved after surgery, the patient eventually developed motor paralysis of the trunk and extremities, and had intractable pneumonia. Tracheal intubation with mechanical ventilation was performed for the managementof respiratory failure, and appropriate antibiotics therapy was continued, however, the patient deteriorated gradually. Because the patient's condition was so critical, it was deemed ill advised to use cytotoxic drugs or radiation therapy. Later, he was complicated with systemic candidiasis, developed dysphagia, and died of aspiration pneumonia on September 29, 1998.
Discussion
The patient described herein had malignant pheochromocytoma which originated in the paraganglionic tissue near the right adrenal gland. Gross and histopathologic characteristics of the primary tumor were not different from those of biologically benign pheochromocytomas. Surgical removal of the tumor was judged to be complete by the operating surgeon and pathologist. Serum NSEconcentration, which has been claimed to be a sensitive marker of malignant pheochromocytoma ( 10), wasnot elevated. Metastases to the cervical spine and the iliac bone became manifest, however, 1 2 years after removal of the primary tumor. This is consistent with the view that the presence of secondary tumor deposits in sites wherechromaffin tissue is not normally present is the only absolute criterion for malignant pheochromocytoma ( 1 1 ).
Of various prognostic factors surveyed by Nativ and coworkers (12) , the most significant factors to predict a future malignant clinical course are large size and local extension of tumor at the time of surgery. In one report, malignant pheochromocytomas had a mean weight of 759 g, while the weight of benign ones averaged 156 g (13) . Compared to these figures, the primary tumor of the present case was muchsmaller. Hence, it should be emphasized that, despite its slow growing nature in general, malignant pheochromocytomapossesses an unlimited growth potential and maymetastasize early in its course. Tumorsizes maysimply depend upon the time of detection especially in the case of incidental pheochromocytoma. The hallmark of pheochromocytoma is hypertension, either paroxysmal or sustained. Most, though not all, patients have episodes of headache, sweating or palpitation (14, 15) . In a series of 21,000 hypertensive patients, the absence of headache, sweating, and palpitation virtually excluded the diagnosis of pheochromocytoma ( 1 5). The present patient, on the other hand, had been asymptomatic and normotensive until several months before his death. Although the hypertension that accompanies pheochromocytoma has been ascribed to the excessive amountof circulating catecholamines released from the tumor, occasional patients maybe normotensive despite harboring an actively catecholamine-secreting pheochromocytoma, as in the present case (7). In fact, Bravo and her colleagues demonstrated a marked discrepancy between the height of blood pressure and the prevailing plasma catecholamine concentrations (16, 17) . To account for the discrepancy, several hypotheses have been postulated. One of the most plausible explanations is desensitization of the cardiovascular system to catecholamines (18, 19) . Unlike the acute administration of catecholamines, long-term exposure to high levels of circulating catecholamines does not produce the hemodynamicresponses characteristic of this group of compounds (17) . However, this was clearly not the case in the present patient; he became hypertensive, and tachycardia and excessive sweating appeared concomitantly with an elevation in plasma noradrenaline levels after osseous metastases, which mayhave been due to an accelerated growth of metastasized tumors. Of relevance in this regard is the finding (20) that, in patients with noradrenalinesecreting pheochromocytoma, plasmanoradrenaline concentration per se is the critical determinant of blood pressure and that the blood pressure is normal in the majority of patients with plasma noradrenaline levels of less than 10 times the upper normal limit.
The treatment of malignant pheochromocytomais unsatisfactory. The use of cytotoxic agents is limited and the results have been rather poor (9, 21) . Effectiveness of radioactive MIBGappears to be partial (22) . Even when distant metastases have occurred, surgical excision of isolated lesions then may be a treatment of choice to removehormonal and mass effects of tumors (21, 23) . To this end, the early detection of metastatic loci is mandatory. A long-term postoperative follow-up with the use of more sensitive biochemical indices and imaging studies maybe required to detect possible metastases of malignant pheochromocytoma early. Furthermore, it would be prudent to consider every case of pheochromocytoma as potentially malignant, since there is no histologic criterion of malignancy in this neoplasm.
